09/09/2026
If you only trust one kind of medical evidence, make it the randomized controlled trial. It's the design that removes wishful thinking: participants are randomly assigned, so the results reflect the intervention, not the enthusiasm of the people who chose it.
In 2025, ReCODE was put to that test, the first trial of its kind for the protocol. Per Apollo Health: 90% of participants improved in the 2025 Randomized Controlled Trial. The trial found statistically significant improvements in memory, executive function, processing speed, and overall cognition, with an effect size 600% greater than the leading FDA-approved Alzheimer's drug. Participants also showed improved blood pressure, insulin sensitivity, and cholesterol levels.
As always: individual outcomes vary, the research is public, and we'll happily send it to you or your doctor.
What would convince YOUR family, or your family's doctor? Tell us what evidence you'd want to see and we'll point you to it.